Eriacta is a prescription medication containing Sildenafil Citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor clinically proven to treat erectile dysfunction. It functions by enhancing blood flow to the penile tissues upon sexual stimulation, facilitating the achievement and maintenance of an erection sufficient for satisfactory sexual activity. This medication is intended for adult males and requires appropriate medical evaluation prior to use to ensure suitability and safety.

Features

• Active ingredient: Sildenafil Citrate 100mg
• Pharmaceutical form: Film-coated tablets
• Rapid onset of action, typically within 30–60 minutes
• Duration of effect: Up to 4–6 hours
• Requires sexual stimulation for efficacy
• Manufactured under strict GMP standards

Benefits

• Clinically demonstrated improvement in erectile function across various etiologies
• Enables spontaneous sexual activity with a broad window of effectiveness
• Supports psychological confidence by providing reliable physiological response
• May improve relationship satisfaction through restored sexual function
• Well-established safety profile with extensive clinical data
• Cost-effective alternative within the Sildenafil-based treatment category

Common use

Eriacta is primarily prescribed for the treatment of erectile dysfunction (ED) in adult males. It is suitable for patients with ED of organic, psychogenic, or mixed etiology. The medication is used on an as-needed basis prior to anticipated sexual activity. It is not indicated for use in women, children, or adolescents. Patients with underlying cardiovascular conditions require thorough assessment before initiation.

Dosage and direction

The recommended starting dose is 50mg taken approximately one hour before sexual activity. Based on efficacy and tolerability, the dose may be increased to 100mg or decreased to 25mg. The maximum recommended dosing frequency is once per 24-hour period. Tablets should be swallowed whole with a glass of water; administration with high-fat meals may delay onset of action. Dose adjustment is necessary for patients with hepatic impairment, severe renal impairment (creatinine clearance <30 mL/min), and those taking certain CYP3A4 inhibitors.

Precautions

Cardiovascular status should be assessed prior to prescribing, as sexual activity carries potential cardiac risk. Patients with pre-existing cardiovascular disease, including unstable angina, hypotension, hypertension, or cardiac failure, require careful evaluation. Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent permanent tissue damage. Use with caution in patients with anatomical penile deformation, bleeding disorders, or active peptic ulceration. Visual disturbances have been reported and may indicate serious ocular conditions.

Contraindications

Concomitant use with organic nitrates or nitric oxide donors in any form. Hypersensitivity to Sildenafil Citrate or any excipients. Patients with severe hepatic impairment, hypotension (BP <90/50 mmHg), recent stroke or myocardial infarction, or hereditary degenerative retinal disorders. Concomitant use with potent CYP3A4 inhibitors in patients with cardiovascular instability.

Possible side effects

• Very common (>10%): Headache, flushing
• Common (1-10%): Dyspepsia, nasal congestion, dizziness, visual disturbances
• Uncommon (0.1-1%): Hypotension, tachycardia, epistaxis, insomnia
• Rare (<0.1%): Priapism, sudden hearing loss, non-arteritic anterior ischemic optic neuropathy
• Frequency not known: Hypersensitivity reactions including skin rashes

Drug interaction

Contraindicated with nitrates due to risk of severe hypotension. Potent CYP3A4 inhibitors (ketoconazole, ritonavir) increase Sriacta exposure—dose adjustment required. Alpha-blockers may potentiate hypotensive effects; separate administration times. CYP3A4 inducers (rifampicin) may decrease efficacy. Grapefruit juice may increase bioavailability. Interaction with alcohol may increase hypotensive effects.

Missed dose

Eriacta is not intended for regular scheduled use. If a dose is missed, take when remembered if sufficient time remains before sexual activity. Do not double dose within 24 hours. The medication should only be taken once per day maximum.

Overdose

Symptoms may include severe headache, visual disturbances, hypotension, syncope, and prolonged erection. Supportive measures should be implemented, including supine positioning with legs elevated for hypotension. Priapism requires immediate urological intervention. Dialysis is not expected to enhance elimination due to high protein binding.

Storage

Store below 30°C in original packaging. Protect from light and moisture. Keep out of reach of children. Do not use after expiration date. Do not flush medications down toilet; dispose of properly through take-back programs.

Disclaimer

This information does not replace professional medical advice. Consult a healthcare provider for proper diagnosis and treatment. Do not use this medication without prescription. Individual results may vary. The manufacturer is not liable for misuse or incorrect administration.

Reviews

Clinical studies demonstrate 82% improvement in erectile function versus 24% with placebo (Goldstein et al., 1998). Patient satisfaction surveys indicate 76% of users report improved ability to achieve erection sufficient for intercourse. Real-world evidence supports maintained efficacy with long-term use when prescribed appropriately. Most common reasons for discontinuation include headache (3.8%) and flushing (2.6%) in clinical trials.